Bottom line
Is FECGX a good fund? The bottom line
FECGX is an index small-cap mutual fund from Fidelity.
It charges 0.05% — about $5 a year on every $10,000 invested, cheaper than 97% of small-cap funds we track.
It returned +13.0% over one year, +3.3% a year over five years (as of Aug 31, 2026, per its prospectus).
With $1.6 billion in net assets and 1,119 holdings, its largest position is Fidelity Revere Street Trust (4.9%) and the top 10 make up 10.5% of the portfolio.
What stands out
- Low cost: cheaper than 97% of small-cap peers
- Broadly diversified (1,119 holdings)
What to watch
- 5-year return in the bottom quarter of its category
Updated Nov 19, 2026
What FECGX invests in
Fidelity Small Cap Growth Index Fund seeks to provide investment results that correspond to the total return of stocks of small-capitalization U.S. companies.
Normally investing at least 80% of assets in securities included in the Russell 2000 Growth Index. The Russell 2000 Growth Index is a market capitalization-weighted index designed to measure the performance of the small-cap growth segment of the U.S. equity market. It includes those Russell 2000 Index companies with higher price-to-book ratios and higher forecasted growth rates. The Russell 2000 Growth Index applies a capping methodology. Index constituents are capped quarterly so that no more than 22.5% of the index weight may be allocated to a single constituent, and the sum of the weights of all constituents representing more than 4.5% of the index should not exceed 45% of the total index weight. Derivative instruments that provide investment exposure to the investments above or exposure to one or more market risk factors associated with such investments are included in the fund's…
From the fund's prospectus (filed Aug 25, 2026).
FECGX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| FECGX | +13.0% | +3.3% | — |
| Small-Cap median | +7.6% | +7.0% | +9.2% |
Source: Fund prospectus, as of Aug 31, 2026
What FECGX costs
On a $10,000 investment, FECGX's 0.05% expense ratio costs about $5 a year. The prospectus estimates $64 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.
FECGX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Fidelity Revere Street Trust | 4.95% |
| 2 | Moog Inc | 0.73% |
| 3 | Brightspring Health Services Inc | 0.68% |
| 4 | Maxlinear Inc | 0.66% |
| 5 | Argan Inc | 0.66% |
| 6 | Jfrog Ltd | 0.59% |
| 7 | Krystal Biotech Inc | 0.58% |
| 8 | Esco Technologies Inc | 0.56% |
| 9 | Firstcash Holdings Inc | 0.53% |
| 10 | D-wave Quantum Inc | 0.53% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 10.5% of the fund. See all top 25 holdings and asset mix →